Published in Minerva Cardioangiol on July 23, 1981
Clinical evaluation of St Jude Medical Hemodynamic Plus versus standard aortic valve prostheses: The Italian multicenter, prospective, randomized study. J Thorac Cardiovasc Surg (2001) 1.43
Mitral valve prolapse. Comparison between valvular repair and replacement in severe mitral regurgitation. J Cardiovasc Surg (Torino) (1999) 1.41
Prevalence, clinical spectrum and atypical symptoms of gastro-oesophageal reflux in Argentina: a nationwide population-based study. Aliment Pharmacol Ther (2005) 1.32
Large-scale survey of naturally occurring HBV polymerase mutations associated with anti-HBV drug resistance in untreated patients with chronic hepatitis B. J Viral Hepat (2011) 0.95
Effect of pleurotomy on pulmonary function after coronary artery bypass grafting with internal mammary artery. Respir Med (1994) 0.92
Hyperinsulinaemia reduces the 24-h virological response to PEG-interferon therapy in patients with chronic hepatitis C and insulin resistance. J Viral Hepat (2010) 0.86
Williams-Beuren syndrome. Long-term results of surgical treatments in six patients. J Cardiovasc Surg (Torino) (1997) 0.86
Echocardiographic findings in a case of acquired pulmonic stenosis from extrinsic compression by a mediastinal cyst. Chest (1981) 0.84
Bjork-Shiley convexo-concave valve: is a prophylactic re-replacement justified? J Cardiovasc Surg (Torino) (1999) 0.83
Complicated removal of a hydatid cyst of the interventricular septum. J Cardiovasc Surg (Torino) (1995) 0.83
Early and late results after surgical therapy of postinfarction left ventricular aneurysm. J Cardiovasc Surg (Torino) (1998) 0.81
Evaluation of friction properties of hydrogels based on a biphasic cartilage model. J Mech Behav Biomed Mater (2013) 0.79
A rare complication of mitral valve replacement: sudden cardiac death for immobilization of disc valve by an unraveled suture. J Cardiovasc Surg (Torino) (1995) 0.79
Aortobronchial fistula after aortic dissection type B. J Cardiovasc Surg (Torino) (2000) 0.79
Solitary fibrous tumor of the pericardium presenting itself as a pericardial effusion and right ventricular obstruction. J Cardiovasc Surg (Torino) (2004) 0.78
Detection of human cytomegalovirus myocardial involvement by polymerase chain reaction during systemic infection and correlation with pp65 antigenemia and DNAemia in infected heart recipients. Transplantation (1996) 0.76
Increased thymocyte differentiation in myasthenia gravis: a dual-color immunofluorescence phenotypic analysis. Ann Neurol (1990) 0.76
Comparison of defibrillation thresholds using monodirectional electrical vector versus bidirectional electrical vector. Ital Heart J (2001) 0.75
Treatment of pectus excavatum: bioabsorbable or metal strut? J Thorac Cardiovasc Surg (1995) 0.75
[Comparison between Doppler CW and Duplex-Scanning in the assessment of silent peripheral vascular lesions in a population of ischemic heart disease patients]. Minerva Cardioangiol (1989) 0.75
Improved tolerance to ischemia in hypertrophied myocardium pre and post cardiopulmonary bypass use of a calcium-channel blocker (diltiazem). Riv Eur Sci Med Farmacol (1987) 0.75
Traumatic rupture of the thoracic aorta. (Report of two unusual cases). J Cardiovasc Surg (Torino) (1981) 0.75
[The lipid hypothesis in the etiopathogenesis of ischemic heart disease: confirmations and doubts resulting from primary prevention trials]. Minerva Cardioangiol (1989) 0.75
[Effects of simvastatin on plasma levels of lipids, lipoproteins and apolipoproteins in primary hypercholesterolemia]. Minerva Cardioangiol (1989) 0.75
[Secondary prevention of ischemic cardiopathy]. Cardiologia (1995) 0.75
[Correlations between risk factors and morphology of carotid atherosclerotic lesions studied with the Duplex-Scanner]. Minerva Cardioangiol (1986) 0.75
[Changes of blood lipid fractions produced by phosphatidyl choline in patients with atherosclerosis]. Minerva Med (1969) 0.75
[Correlation between malfunction of a bioprosthesis and deformation of a valve stent. Comparison of three different vale models]. Minerva Cardioangiol (1998) 0.75
[Conservative surgical treatment of rheumatic mitral stenosis]. Cardiologia (1995) 0.75
[Porcine aortic valves as bioprostheses in man. Morphological changes of prostheses after implantation for various periods]. Schweiz Arch Tierheilkd (1980) 0.75
[Indications for the surgical treatment of left ventricular aneurysms]. Boll Soc Ital Cardiol (1980) 0.75
[Hypertension and arteriosclerosis. Correlations and prospects of preventive therapy]. Minerva Cardioangiol (1976) 0.75
When coronary angiography is not enough to detect spontaneous left main coronary artery dissection. Minerva Cardioangiol (2012) 0.75
[Left atrial myxoma and calcified aortic stenosis in a patient with syncope]. G Ital Cardiol (1983) 0.75
[The electrocardiogram and arterial hypertension in primary hyperparathyroidism]. Minerva Med (1979) 0.75
[Correlations between risk factors and atherosclerotic disease of the carotid arteries. Investigation with the Duplex scanner]. Minerva Cardioangiol (1986) 0.75
Rupture of thoracic aorta resulting from blunt trauma. Int Surg (1997) 0.75
[Female sex is not an independent risk factor in mortality during myocardial revascularization]. Cardiologia (1997) 0.75
[Attempted athero-regression]. Minerva Cardioangiol (1981) 0.75
[Chylothorax after heart surgery intervention. Description of an atypical case]. Minerva Cardioangiol (1988) 0.75
[Current dietetic and pharmacological treatment of hyperlipoproteinemia]. Minerva Med (1975) 0.75
The dacron aorta. J Cardiovasc Surg (Torino) (1998) 0.75
Twelve-year follow up with the Sorin Pericarbon bioprosthesis in the mitral position. J Heart Valve Dis (1998) 0.75
[Aortic coarctation and aneurysms of the ascending aorta]. G Ital Cardiol (1985) 0.75
[Giant-cell temporal arteritis with the aortic arch syndrome. Description of a clinical case]. Minerva Med (1968) 0.75
Coronary stenting: single institution experience with the initial 100 cases using the Palmaz-Schatz stent. Cathet Cardiovasc Diagn (1992) 0.75
Preservation of myocardial ultrastructural integrity following ischemic arrest. Clinical use of nifedipine cardioplegia. Preliminary report. Riv Eur Sci Med Farmacol (1987) 0.75
[On a case of recurrent ventricular fibrillation with favorable course]. Minerva Cardioangiol (1967) 0.75
Morphological comparison of mitral and aortic bioprostheses explanted from the same patient for primary tissue failure. J Cardiovasc Surg (Torino) (1996) 0.75
[Surgical revascularization of the myocardium]. Minerva Cardioangiol (1981) 0.75
Left atrial approach to big myxoma with angiographically visible neovascularity. Report of one case. J Cardiovasc Surg (Torino) (1999) 0.75
[Single cell preparation of the human heart. Technic of dissociation and isolation of myocytes]. Minerva Cardioangiol (1990) 0.75
[Treatment using radiofrequency stimulation of supraventricular paroxysmal tachycardia in W.P.W. syndrome]. Minerva Med (1981) 0.75
[The action of 1,4-dicaffeylquinic acid on the lipid fractions of the blood in atherosclerosis]. Minerva Med (1969) 0.75
[The biological prostheses of Hancock in our experience of 250 subjects underwent a valvular replacement (author's transl)]. G Ital Cardiol (1977) 0.75
Coronary artery bypass grafting for unstable angina. Risk factors of operative mortality. J Cardiovasc Surg (Torino) (1984) 0.75
[Re-operations in patients with cardiac valve prostheses]. Minerva Cardioangiol (1981) 0.75
[Coronary anastomotic circulation and left ventricular aneurysm]. Boll Soc Ital Cardiol (1980) 0.75
[Pulmonary artery banding in interventricular septal defects. Surgical methods and results]. Chir Ital (1978) 0.75
[Antibiotic prophylaxis in cardiovascular surgery: comparison of sulbactam-ampicillin and cefuroxime]. Riv Eur Sci Med Farmacol (1994) 0.75
[Studies of the hepatotoxicity of triacetyloleandomycin (TAO) in humans]. Minerva Med (1969) 0.75
[Coronary angiography in primary myocardial diseases]. Minerva Cardioangiol (1975) 0.75
[Correction of the primary and secondary risk factors in coronary dis]. Minerva Cardioangiol (1981) 0.75
[The administration of an association of sodium nitroprusside and adrenaline in cardiac surgery (author's transl)]. G Ital Cardiol (1978) 0.75
[Prolonged treatment of coronary insufficiency with heparin in clarifying doses and essential phospholipids]. Therapeutique (1969) 0.75
[Familial aggregation of ischemic cardiopathy]. Minerva Cardioangiol (1986) 0.75
[Surgical cardiac risk in patients with heart diseases. II. Perioperative treatment]. Minerva Cardioangiol (1989) 0.75
[Cardioangiographic aspects, changes in the subvalvular apparatus and surgical implications in pure mitral stenosis]. Boll Soc Ital Cardiol (1978) 0.75
[Surgical cardiac risk in patients with heart diseases. I. Evaluation of the risk]. Minerva Cardioangiol (1989) 0.75
[Right atrial myxoma. Review of the literature and a case report]. G Ital Cardiol (1982) 0.75
[Effect of various risk factors on long-term survival in ischemic heart disease]. Minerva Cardioangiol (1984) 0.75
Mitral annulus size in isolated mitral stenosis. J Heart Valve Dis (1993) 0.75
[Aortic dissection in pregnancy: report of 2 cases]. G Ital Cardiol (1994) 0.75
[Myocardial protection from cardioplegic and hypothermia during aortic cross-clamping (author's ttrans)]. G Ital Cardiol (1979) 0.75
[Isiopathic diffuse calcinosis and arteriosclerosis. Considerations on a case of idiopathic diffuse calcinosis with arteriosclerosis obliterans of the lower limbs]. Minerva Cardioangiol (1976) 0.75
[Aortic dissection after aortic valve replacement: clinical and anatomic features]. G Ital Cardiol (1992) 0.75
[Effects of medical therapy on long-term survival in ischemic heart disease]. Minerva Cardioangiol (1984) 0.75
Low IGF-I levels are often uncoupled with elevated GH levels in catabolic conditions. J Endocrinol Invest (1998) 0.75
[Diagnostic problems in the aortic arch syndrome. Clinical contribution on 5 cases]. Minerva Med (1968) 0.75
[Correction of thrombophilia]. Minerva Cardioangiol (1981) 0.75
[The lipid profile after heart transplantation in relation to the preoperative cholesterolemia and to the main pathology]. Cardiologia (1993) 0.75
[Bicameral stimulation in a case of corrected transposition of the great vessels]. G Ital Cardiol (1986) 0.75
[Rupture of left ventricular pseudoaneurysm in a patient with diagnosis of unstable angina]. G Ital Cardiol (1990) 0.75
Mortality and morbidity in reoperation comparing to first intervention in coronary revascularization. J Cardiovasc Surg (Torino) (2001) 0.75
[Left ventricular aneurysms. Surgical treatment and results]. Minerva Cardioangiol (1981) 0.75
Bovine pericardial bioprosthesis in mitral position. A ten-year follow-up. Minerva Cardioangiol (1999) 0.75
[Anti-hyperlipemic therapy in the secondary prevention of coronary heart disease. Long-term study]. Boll Soc Ital Cardiol (1974) 0.75
[So-called idiopathic auricular fibrillation. Coronaro-cineventriculographic study]. Minerva Cardioangiol (1976) 0.75
[Inhibition of myopotentials in 179 unipolar pacemakers. Clinical evaluation and therapeutic indications]. Minerva Cardioangiol (1987) 0.75
[Coronary fistula in the right ventricle]. Chir Ital (1975) 0.75
Intrathymic lymphoid cell differentiation in myasthenia gravis: an immunophenotypic study. Ital J Neurol Sci (1991) 0.75